port/human/002583/WC500140326.pdf [retrieved on 2017-10-13], SINCLAIR JOHN DAVID:

"Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism", ALCOHOL AND ALCOHOLISM, PERGAMON, OXFORD, GB, vol.36, no.1, 1 January 2001 (2001-01-01), pages 2-10, XP002958401, ISSN: 0735-0414, DOI:

10.1093/ALCALC/36.1.2, SAKARI KARHUVAARA ET AL: "Targeted Nalmefene With Simple Medical Management in the Treatment of Heavy Drinkers: A Randomized Double-Blind Placebo-Controlled Multicenter Study", ALCOHOLISM: CLINICAL AND EXPERIMENTAL RESEARCH., vol.31, no.7, 19 April 2007 (2007-04-19) , pages 1179-1187, XP055072462, US ISSN: 0145-6008, DOI: 10.1111/j.1530-0277.2007.00401.x

Enclosed is a translation of the patent claims in Norwegian. Please note that as per the Norwegian Patents Acts, section 66i the patent will receive protection in Norway only as far as there is agreement between the translation and the language of the application/patent granted at the EPO. In matters concerning the validity of the patent, language of the application/patent granted at the EPO will be used as the basis for the decision. The patent documents published by the EPO are available through Espacenet (http://worldwide.espacenet.com) or via the search engine on our website here: https://search.patentstyret.no/